Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Mar 12, 2026, before the open
10-K filed Mar 12, 2026, 71 days after period end · 0001193125-26-104158
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $7.24M | $6.33M | $5.23M |
| Net Income | -$23.25M |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$18.27M |
| -$16.27M |
| -$13.91M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.